Mala Gaonkar is co-portfolio manager at investment firm Lone Pine Capital LLC, a role she has held since 1998. After graduating in economics at Harvard in 1991, she worked for The Boston Consulting Group, primarily in Munich and Hong Kong and completed her MBA at Harvard Business School before Lone Pine’s inception.

She is a trustee of the Clinton Health Access Initiative (CHAI), of Ariadne Labs (a joint venture between Brigham and Women’s Hospital and The Harvard School of Public Health) and of the Global Health Delivery Partnership. She is also a trustee of The Paris Review Foundation and of Tate.